IFN-γ makes host cells in the gastrointestinal tract and skin more susceptible to GvHD [78,79], while IL-17 will increase the production of IL-6 and IFN-γ in the early stage of the disease [80,81]. This evidence concerns the gene IL17A and graft versus host disease.